ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00823862
Recruitment Status : Completed
First Posted : January 16, 2009
Last Update Posted : March 1, 2018
Sponsor:
Collaborators:
Synteract, Inc.
PPD
Information provided by (Responsible Party):
Dynavax Technologies Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2009
  Actual Study Completion Date : February 2010